JESSICA KELLEY: Open Payments
NPI 1922551324 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,366 in 21 payments from 11 companies in 2025. Trend: 2023 $685 · 2024 $1,999 · 2025 $2,366
Food & beverage: $2,366
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $595 |
| Gilead Sciences, Inc. | 3 | $369 |
| Abbott Laboratories | 3 | $320 |
| Edwards Lifesciences Corporation | 1 | $173 |
| Shockwave Medical, Inc | 1 | $167 |
| Cleerly, Inc. | 2 | $149 |
| ABBVIE INC. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Phadia US Inc. | 2 | $117 |
Products named: BREZTRI, Yeztugo, AIRSUPRA, SAPIEN 3 Ultra RESILIA, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Cleerly Ischemia, UBRELVY, Wegovy.
Industry payments across CA — which companies pay providers there.
